Product Information
DOXYCYCLINE MONO 100 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2489 per EA under NDC 70710112307. Its NADAC has been published 428 times since Jul 25, 2018.
FDA first approved this application on Sep 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710112307
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA209582FDA Approved
9/28/2017
TE Code
AB
On Market Since
1/11/2018
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE MONO 100 MG TABLET has been published 428 times since Jul 25, 2018, and over the history we have for it it has declined 48.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2489 per EA |
|---|---|
| All-time high | $0.5090 (Oct 16, 2019) |
| All-time low | $0.1986 (Nov 20, 2024) |
| 52-week high | $0.2779 |
| 52-week low | $0.2480 |
| Median price | $0.3259 |
| Average price | $0.3405 |
| Largest weekly change | +44.0% (Aug 21, 2024) |
| Weeks tracked | 428 |
| Tracking since | Jul 25, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxycycline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE MONO 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE MONO 100 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2489 per EA (NDC 70710112307), effective Sep 30, 2026.
How has the price of DOXYCYCLINE MONO 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE MONO 100 MG TABLET has declined 48.7%. It has been tracked across 428 weekly CMS publications since Jul 25, 2018.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE MONO 100 MG TABLET?
Since Jul 25, 2018, the NADAC for DOXYCYCLINE MONO 100 MG TABLET has ranged from a low of $0.1986 (Nov 20, 2024) to a high of $0.5090 (Oct 16, 2019), with a median of $0.3259 per EA.
Are there cheaper alternatives to DOXYCYCLINE MONO 100 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXYCYCLINE MONO 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXYCYCLINE MONO 100 MG TABLET?
DOXYCYCLINE MONO 100 MG TABLET (NDC 70710112307) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.